SCM Lifescience Co., Ltd. (KOSDAQ:298060)
953.00
-5.00 (-0.52%)
At close: May 9, 2025, 3:30 PM KST
SCM Lifescience Revenue
In the year 2024, SCM Lifescience had annual revenue of 824.80M KRW with 18.56% growth. SCM Lifescience had revenue of 160.17M in the quarter ending December 31, 2024, a decrease of -28.75%.
Revenue
824.80M
Revenue Growth
+18.56%
P/S Ratio
32.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 824.80M | 129.10M | 18.56% |
Dec 31, 2023 | 695.70M | 299.72M | 75.69% |
Dec 31, 2022 | 395.98M | -43.28M | -9.85% |
Dec 31, 2021 | 439.26M | 119.26M | 37.27% |
Dec 31, 2020 | 320.01M | 151.51M | 89.92% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.07T |
SK hynix | 71.40T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 11.24T |
HD Hyundai Heavy Industries | 14.49T |
Kia Corporation | 107.45T |